Analysts Offer Insights on Healthcare Companies: Sumitomo Dainippon Pharma Co (OtherDNPUF) and Sanofi (OtherSNYNF)
Analysts fell to the sidelines weighing in on Sumitomo Dainippon Pharma Co (DNPUF – Research Report) and Sanofi (SNYNF – Research Report) with ...
pharmaphorum3d
Exscientia starts trials of AI-designed Alzheimer's drug
The new molecule – called DSP-0038 – is being developed by Japan's Sumitomo Dainippon Pharma (DSP), which is now starting a phase 1 trial in the US as a treatment for psychosis associated with ...
pharmaphorum21d
Exscientia claims world first as AI-created drug enters clinic
UK-based Exscientia has been working with Japanese pharma Sumitomo Dainippon Pharma (DSP) on the drug for obsessive-compulsive disorder (OCD), and the trial aims to measure its efficacy.